In summary, the results of this study identified the TCONS_00026334 acts as an anti‐tumor and anti‐metastatic gene to inhibit CRC development by competitively binding miR‐548n, upregulating TP53INP1 expression. This evidence concerns the gene TP53INP1 and colorectal carcinoma.